logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Genelux Corporation


USPTO Granted Patents = 30

% Expired Patents = 40.0



Forward Citations = 1,170

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Aladar A Szalay (29 out of 44 patents)

silverMedal Yong A Yu (25 out of 25 patents)

bronzeMedal Qian Zhang (19 out of 61 patents)

4.  Tatyana Timiryasova (13 out of 13 patents)

5.  Nanhai G Chen (10 out of 15 patents)

6.  Alexa Frentzen (4 out of 4 patents)

7.  Shahrokh Shabahang (4 out of 5 patents)

8.  Jochen Harald Stritzker (4 out of 4 patents)

9.  Joseph Cappello (2 out of 26 patents)

10.  Phil Hill (2 out of 2 patents)

11.  Boris Minev (1 out of 10 patents)

12.  Richard J Aguilar (1 out of 1 patent)

13.  Jochen Stritzker (1 out of 3 patents)

14.  Michael Hess (1 out of 1 patent)

15.  Yuman Fong (4 patents)


Core Competencies:
Oncolytic Viruses
Vaccinia Virus
Bioreactor Production
Diagnostic Methods
Therapeutic Methods
Microorganisms
Tumor Imaging
Virus Infectivity
Light Emitting Cells
Bacterial Detection
Disease Treatment
Inflamed Tissue

30 patents:

1. 12338464 - Clonal strains of attenuated vaccinia viruses and methods of use thereof (2025-06-24),
2. 11149254 - Clonal strains of attenuated vaccinia viruses and methods of use thereof (2021-10-19),
3. 10851350 - Bioreactor production of virus from adherent cells (2020-12-01),
4. 10584317 - Modified vaccinia virus strains for use in diagnostic and therapeutic methods (2020-03-10),
5. 10463730 - Microorganisms for therapy (2019-11-05),
6. 10238700 - Oncolytic virus adjunct therapy with agents that increase virus infectivity (2019-03-26),
7. 9944903 - Modified vaccinia virus strains for use in diagnostic and therapeutic methods (2018-04-17),
8. 9492534 - Microorganisms for therapy (2016-11-15),
9. 9005602 - Modified vaccinia virus strains for use in diagnostic and therapeutic methods (2015-04-14),
10. 8865153 - Microorganisms for imaging and/or treatment of tumors (2014-10-21),
11. 8859256 - Method for detecting replication or colonization of a biological therapeutic (2014-10-14),
12. 8852927 - Microorganisms for imaging and/or treatment of tumors (2014-10-07),
13. 8784836 - Microorganisms for therapy (2014-07-22),
14. 8642257 - Vaccinia virus for diagnosis and therapy of tumors (2014-02-04),
15. 8586022 - Light emitting microorganisms and cells for diagnosis and therapy of tumors (2013-11-19),
Genelux Corporation is a biotechnology company based in San Diego, California, specializing in the development of innovative oncolytic virus therapies for cancer treatment. The company focuses on harnessing the power of genetically engineered viruses to selectively target and destroy cancer cells while sparing healthy tissue. With a commitment to advancing cancer therapeutics, Genelux is at the forefront of research in viral immunotherapy, aiming to improve patient outcomes through its cutting-edge technology and scientific expertise.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Genelux Corporation
30 Patents

#209 in San Diego, CA

#2,677 in California

#11,257 in US

#21,853 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Genelux Corporation

Forward Citations = 1,170

14 inventors:

goldMedal Aladar A Szalay (29 out of 44 patents)

silverMedal Yong A Yu (25 out of 25 patents)

bronzeMedal Qian Zhang (19 out of 61 patents)

4.  Tatyana Timiryasova (13 out of 13 patents)

5.  Nanhai G Chen (10 out of 15 patents)

Please report any incorrect information to [email protected]
Loading…